{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T08:53:09Z","timestamp":1778403189022,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1038\/89040","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:43:34Z","timestamp":1027673014000},"page":"667-671","source":"Crossref","is-referenced-by-count":170,"title":["Advances in schizophrenia"],"prefix":"10.1038","volume":"7","author":[{"given":"Gunvant K.","family":"Thaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"William T.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnm0601_667_CR1","unstructured":"Kraepelin, E. Dementia Praecox and Paraphrenia. (Huntington, New York, 1919)."},{"key":"BFnm0601_667_CR2","volume-title":"Demential Praecox or the Group of Schizophrenias","author":"M Bleuler","year":"1950","unstructured":"Bleuler, M. Demential Praecox or the Group of Schizophrenias. (International Universities Press, New York, 1950)."},{"key":"BFnm0601_667_CR3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1176\/ajp.155.11.1550","volume":"155","author":"A Abi-Dargham","year":"1998","unstructured":"Abi-Dargham, A. et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am. J. Psychiatry 155, 761\u2013767 (1998).","journal-title":"Am. J. Psychiatry"},{"key":"BFnm0601_667_CR4","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1073\/pnas.94.6.2569","volume":"94","author":"A Breier","year":"1997","unstructured":"Breier, A. et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method. Proc. Natl. Acad. Sci. USA 94, 2569\u20132574 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0601_667_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1615\/CritRevNeurobiol.v12.i1-2.20","volume":"12","author":"CA Tamminga","year":"1998","unstructured":"Tamminga, C.A. Schizophrenia and glutamatergic transmission. Crit. Rev. Neurobiol. 12, 21\u201336 (1998).","journal-title":"Crit. Rev. Neurobiol."},{"key":"BFnm0601_667_CR6","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1073\/pnas.91.12.5720","volume":"91","author":"JF Smiley","year":"1994","unstructured":"Smiley, J.F., Levey, A.I., Ciliax, B.J. & Goldman-Rakic, P.S. D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. Proc. Natl. Acad. Sci. USA 91, 5720\u20135724 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0601_667_CR7","doi-asserted-by":"publisher","first-page":"7821","DOI":"10.1523\/JNEUROSCI.15-12-07821.1995","volume":"15","author":"C Bergson","year":"1995","unstructured":"Bergson, C. et al. Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J. Neurosci. 15, 7821\u20137836 (1995).","journal-title":"J. Neurosci."},{"key":"BFnm0601_667_CR8","doi-asserted-by":"publisher","first-page":"9788","DOI":"10.1523\/JNEUROSCI.19-22-09788.1999","volume":"19","author":"S Otani","year":"1999","unstructured":"Otani, S., Auclair, N., Desce, J.M., Roisin, M.P. & Crepel, F. Dopamine receptors and groups I and II mGluRs cooperate for long-term depression induction in rat prefrontal cortex through converging postsynaptic activation of MAP kinases. J. Neurosci. 19, 9788\u20139802 (1999).","journal-title":"J. Neurosci."},{"key":"BFnm0601_667_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1073\/pnas.98.1.301","volume":"98","author":"JK Seamans","year":"2001","unstructured":"Seamans, J.K., Durstewitz, D., Christie, B.R., Stevens, C.F. & Sejnowski, T.J. Dopamine D1\/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. Proc. Natl. Acad. Sci. USA 98, 301\u2013306 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0601_667_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1073\/pnas.98.1.295","volume":"98","author":"WJ Gao","year":"2001","unstructured":"Gao, W.J., Krimer, L.S. & Goldman-Rakic, P.S. Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits. Proc. Natl. Acad. Sci. USA 98, 295\u2013300 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0601_667_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0165-0173(99)00041-7","volume":"31","author":"FM Benes","year":"2000","unstructured":"Benes, F.M. Emerging principles of altered neural circuitry in schizophrenia. Brain Res. Brain Res. Rev. 31, 251\u2013269 (2000).","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"Suppl. 4","key":"BFnm0601_667_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/PL00014181","volume":"249","author":"B Bogerts","year":"1999","unstructured":"Bogerts, B. The neuropathology of schizophrenic diseases: historical aspects and present knowledge. Eur. Arch. Psychiatry Clin. Neurosci. 249 (Suppl. 4), 2\u201313 (1999).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"BFnm0601_667_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/archpsyc.57.5.471","volume":"57","author":"M Sanfilipo","year":"2000","unstructured":"Sanfilipo, M. et al. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. Arch. Gen. Psychiatry 57, 471\u2013480 (2000).","journal-title":"Arch. Gen. Psychiatry"},{"key":"BFnm0601_667_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0006-3223(98)00281-9","volume":"45","author":"LD Selemon","year":"1999","unstructured":"Selemon, L.D. & Goldman-Rakic, P.S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 45, 17\u201325 (1999).","journal-title":"Biol. Psychiatry"},{"key":"BFnm0601_667_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/archpsyc.57.1.65","volume":"57","author":"LA Glantz","year":"2000","unstructured":"Glantz, L.A. & Lewis, D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 57, 65\u201373 (2000).","journal-title":"Arch. Gen. Psychiatry"},{"key":"BFnm0601_667_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-3223(00)01058-1","volume":"49","author":"MS Lidow","year":"2001","unstructured":"Lidow, M.S. et al. Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex. Biol. Psychiatry 49, 1\u201312 (2001).","journal-title":"Biol. Psychiatry"},{"key":"BFnm0601_667_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0896-6273(00)00085-4","volume":"28","author":"K Mirnics","year":"2000","unstructured":"Mirnics, K., Middleton, F.A., Marquez, A., Lewis, D.A. & Levitt, P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28, 53\u201367 (2000).","journal-title":"Neuron"},{"key":"BFnm0601_667_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1001\/archpsyc.1988.01800260109013","volume":"45","author":"SA Mednick","year":"1988","unstructured":"Mednick, S.A., Machon, R.A., Huttunen, M.O. & Bonett, D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch. Gen. Psychiatry 45, 189\u2013192 (1988).","journal-title":"Arch. Gen. Psychiatry"},{"key":"BFnm0601_667_CR19","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1073\/pnas.061021998","volume":"98","author":"H Karlsson","year":"2001","unstructured":"Karlsson, H. et al. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc. Natl. Acad. Sci. USA 98, 4634\u20134639 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0601_667_CR20","first-page":"942","volume-title":"Comprehensive Textbook of Psychiatry.","author":"KS Kendler","year":"1995","unstructured":"Kendler, K.S. & Diehl, S.R. Schizophrenia: Genetics. in Comprehensive Textbook of Psychiatry. Vol. VI (eds. Kaplan, H.I. & Sadock, B.J.) 942\u2013957 (Williams and Wilkins, Baltimore, Maryland, 1995)."},{"key":"BFnm0601_667_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1001\/archpsyc.55.1.67","volume":"55","author":"TD Cannon","year":"1998","unstructured":"Cannon, T.D., Kaprio, J., Lonnqvist, J., Huttunen, M. & Koskenvuo, M. The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch. Gen. Psychiatry 55, 67\u201374 (1998).","journal-title":"Arch. Gen. Psychiatry"},{"key":"BFnm0601_667_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3109\/hrp.7.4.185","volume":"7","author":"MT Tsuang","year":"1999","unstructured":"Tsuang, M.T., Stone, W.S. & Faraone, S.V. Schizophrenia: a review of genetic studies. Harv. Rev. Psychiatry 7, 185\u2013207 (1999).","journal-title":"Harv. Rev. Psychiatry"},{"key":"BFnm0601_667_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0006-3223(99)00281-4","volume":"47","author":"AE Pulver","year":"2000","unstructured":"Pulver, A.E. Search for schizophrenia susceptibility genes. Biol. Psychiatry 47, 221\u2013230 (2000).","journal-title":"Biol. Psychiatry"},{"key":"BFnm0601_667_CR24","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s11920-000-0022-6","volume":"2","author":"GK Thaker","year":"2000","unstructured":"Thaker, G.K. Defining the schizophrenia phenotype. Current Psychiatry Reports 2, 398\u2013403 (2000).","journal-title":"Current Psychiatry Reports"},{"key":"BFnm0601_667_CR25","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1176\/ajp.145.7.902","volume":"145","author":"WT Carpenter Jr","year":"1988","unstructured":"Carpenter, W.T. Jr, Heinrichs, D.W. & Wagman, A.M. Deficit and nondeficit forms of schizophrenia: The concept. Am. J. Psychiatry 145, 578\u2013583 (1988).","journal-title":"Am. J. Psychiatry"},{"key":"BFnm0601_667_CR26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1176\/ajp.151.3.351","volume":"151","author":"WS Fenton","year":"1994","unstructured":"Fenton, W.S. & McGlashan, T.H. Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. Am. J. Psychiatry 151, 351\u2013356 (1994).","journal-title":"Am. J. Psychiatry"},{"key":"BFnm0601_667_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0920-9964(96)00114-4","volume":"23","author":"RW Waltrip","year":"1997","unstructured":"Waltrip, R.W. et al. Borna disease virus antibodies and the deficit syndrome of schizophrenia. Schizophr. Res. 23, 253\u2013257 (1997).","journal-title":"Schizophr. Res."},{"key":"BFnm0601_667_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/archpsyc.58.2.165","volume":"58","author":"B Kirkpatrick","year":"2001","unstructured":"Kirkpatrick, B., Buchanan, R.W., Ross, D.E. & Carpenter, W.T.J. A separate disease within the syndrome of schizophrenia. Arch. Gen. Psychiatry 58, 165\u2013171 (2001).","journal-title":"Arch. Gen. Psychiatry"},{"key":"BFnm0601_667_CR29","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1176\/appi.ajp.157.7.1071","volume":"157","author":"DE Ross","year":"2000","unstructured":"Ross, D.E. et al. Sibling correlation of deficit syndrome in the Irish study of high-density schizophrenia families. Am. J. Psychiatry 157, 1071\u20131076 (2000).","journal-title":"Am. J. Psychiatry"},{"key":"BFnm0601_667_CR30","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1001\/archpsyc.1992.01820070016003","volume":"49","author":"CA Tamminga","year":"1992","unstructured":"Tamminga, C.A. et al. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch. Gen. Psychiatry 49, 522\u2013530 (1992).","journal-title":"Arch. Gen. Psychiatry"},{"key":"BFnm0601_667_CR31","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/archpsyc.1993.01820220081009","volume":"50","author":"WT Carpenter Jr","year":"1993","unstructured":"Carpenter, W.T. Jr, Buchanan, R.W., Kirkpatrick, B., Tamminga, C.A. & Wood, F. Strong inference, theory testing, and the neuroanatomy of schizophrenia. Arch. Gen. Psychiatry 50, 825\u2013831 (1993).","journal-title":"Arch. Gen. Psychiatry"},{"key":"BFnm0601_667_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.181.4095.179","volume":"181","author":"PS Holzman","year":"1973","unstructured":"Holzman, P.S., Proctor, L.R. & Hughes, D.W. Eye-tracking patterns in schizophrenia. Science 181, 179\u2013181 (1973).","journal-title":"Science"},{"key":"BFnm0601_667_CR33","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/(SICI)1096-8628(19961122)67:6<564::AID-AJMG10>3.0.CO;2-R","volume":"67","author":"V Arolt","year":"1996","unstructured":"Arolt, V. et al. Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease. Am. J Med. Genet. 67, 564\u2013579 (1996).","journal-title":"Am. J Med. Genet."},{"key":"BFnm0601_667_CR34","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/archpsyc.1994.03950080063009","volume":"51","author":"TD Cannon","year":"1994","unstructured":"Cannon, T.D. et al. Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. Arch. Gen. Psychiatry 51, 651\u2013661 (1994).","journal-title":"Arch. Gen. Psychiatry"},{"key":"BFnm0601_667_CR35","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/S0006-3223(98)00264-9","volume":"44","author":"JH Callicott","year":"1998","unstructured":"Callicott, J.H. et al. Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype. Biol. Psychiatry 44, 941\u2013950 (1998).","journal-title":"Biol. Psychiatry"},{"key":"BFnm0601_667_CR36","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0006-3223(98)00321-7","volume":"45","author":"R Freedman","year":"1999","unstructured":"Freedman, R., Adler, L.E. & Leonard, S. Alternative phenotypes for the complex genetics of schizophrenia. Biol. Psychiatry 45, 551\u2013558 (1999).","journal-title":"Biol. Psychiatry"},{"key":"BFnm0601_667_CR37","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1073\/pnas.94.2.587","volume":"94","author":"R Freedman","year":"1997","unstructured":"Freedman, R. et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. USA 94, 587\u2013592 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0601_667_CR38","unstructured":"Freedman, R. & Leonard, S. Schizophrenia and 15q14. Am. J. Med. Genet. (in the press)."},{"key":"BFnm0601_667_CR39","doi-asserted-by":"crossref","unstructured":"Carlsson, A. & Lindquist, M. Effect of chlorpromazine and haloperidol of formation of 3- methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol. Toxicol. 140\u2013144 (1963).","DOI":"10.1111\/j.1600-0773.1963.tb01730.x"},{"key":"BFnm0601_667_CR40","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","volume":"45","author":"J Kane","year":"1988","unstructured":"Kane, J., Honigfeld, G., Singer, J. & Meltzer, H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch. Gen. Psychiatry 45, 789\u2013796 (1988).","journal-title":"Arch. Gen. Psychiatry"},{"key":"BFnm0601_667_CR41","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1176\/ajp.152.5.815","volume":"152","author":"DC Goff","year":"1995","unstructured":"Goff, D.C., Tsai, G., Manoach, D.S. & Coyle, J.T. Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am. J. Psychiatry 152, 1213\u20131215 (1995).","journal-title":"Am. J. Psychiatry"},{"key":"BFnm0601_667_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archpsyc.56.1.29","volume":"56","author":"U Heresco-Levy","year":"1999","unstructured":"Heresco-Levy, U. et al. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch. Gen. Psychiatry 56, 29\u201336 (1999).","journal-title":"Arch. Gen. Psychiatry"},{"key":"BFnm0601_667_CR43","doi-asserted-by":"crossref","unstructured":"Mirnics, K., Middleton, F.A., Stanwood, G.D., Lewis, D.A. & Levitt, P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol. Psychiatry, 293\u2013301 (2001).","DOI":"10.1038\/sj.mp.4000866"},{"key":"BFnm0601_667_CR44","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1126\/science.288.5466.678","volume":"288","author":"LM Brzustowicz","year":"2000","unstructured":"Brzustowicz, L.M., Hodgkinson, K.A., Chow, E.W., Honer, W.G. & Bassett, A.S. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 288, 678\u2013682 (2000).","journal-title":"Science"},{"key":"BFnm0601_667_CR45","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/336164a0","volume":"336","author":"R Sherrington","year":"1988","unstructured":"Sherrington, R. et al. Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature 336, 164\u2013167 (1988).","journal-title":"Nature"},{"key":"BFnm0601_667_CR46","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/(SICI)1096-8628(19961122)67:6<564::AID-AJMG10>3.0.CO;2-R","volume":"67","author":"V Arolt","year":"1996","unstructured":"Arolt, V. et al. Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease. Am. J. Med. Genet. 67, 564\u2013579 (1996).","journal-title":"Am. J. Med. Genet."},{"key":"BFnm0601_667_CR47","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/sj.mp.4000814","volume":"5","author":"AE Pulver","year":"2000","unstructured":"Pulver, A.E. et al. Genetic heterogeneity in schizophrenia: stratification of genome scan data using co-segregating related phenotypes. Mol. Psychiatry 5, 650\u2013653 (2000).","journal-title":"Mol. Psychiatry"},{"key":"BFnm0601_667_CR48","doi-asserted-by":"publisher","first-page":"5604","DOI":"10.1073\/pnas.96.10.5604","volume":"96","author":"SD Detera-Wadleigh","year":"1999","unstructured":"Detera-Wadleigh, S.D. et al. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc. Natl. Acad. Sci. USA 96, 5604\u20135609 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0601_667_CR49","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/(SICI)1096-8628(19991015)88:5<544::AID-AJMG20>3.0.CO;2-V","volume":"88","author":"M Myles-Worsley","year":"1999","unstructured":"Myles-Worsley, M. et al. Linkage of a composite inhibitory phenotype to a chromosome 22q locus in eight Utah families. Am. J. Med. Genet. 88, 544\u2013550 (1999).","journal-title":"Am. J. Med. Genet."},{"key":"BFnm0601_667_CR50","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/0140-6736(92)90734-K","volume":"339","author":"PJ Scambler","year":"1992","unstructured":"Scambler, P.J. et al. Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet 339, 1138\u20131139 (1992).","journal-title":"Lancet"},{"key":"BFnm0601_667_CR51","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1073\/pnas.98.2.585","volume":"98","author":"JR Kelsoe","year":"2001","unstructured":"Kelsoe, J.R. et al. A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. Proc. Natl. Acad. Sci. USA 98, 585\u2013590 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0601_667_CR52","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1086\/318212","volume":"68","author":"M Baron","year":"2001","unstructured":"Baron, M. Genetics of schizophrenia and the new millennium: progress and pitfalls. Am. J. Hum. Genet. 68, 299\u2013312 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnm0601_667_CR53","unstructured":"Egan, M.F. et al. Effect of COMT val108\/158met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. USA (in the press)."},{"key":"BFnm0601_667_CR54","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0006-3223(00)00883-0","volume":"48","author":"WH Berrettini","year":"2000","unstructured":"Berrettini, W.H. Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol. Psychiatry 48, 531\u2013538 (2000).","journal-title":"Biol. Psychiatry"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0601_667.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0601_667","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0601_667.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:45:56Z","timestamp":1684449956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0601_667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["BFnm0601_667"],"URL":"https:\/\/doi.org\/10.1038\/89040","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}